Viking Therapeutics, Inc.
VKTX$26.65−5.50% 1D
$25.7752-week range$43.15
Updated . Prices are snapshots and may be delayed.
Viking Therapeutics, Inc. price chart
−7.80% over 7D
$28.72
$25.42
Oct 18
Oct 20
AI Outlook for Viking Therapeutics, Inc.
Bearish posture- Long-term trend-16.6% vs 200-day average
- Medium-term trend-15.4% vs 50-day average
- Averages50-day below 200-day
- 3 more trend and momentum checks
- Nearby support and resistance levels
- What would strengthen or weaken the picture
Posture describes where the price stands today, from its own trend and momentum. It is not a forecast, a price target or financial advice. How it is worked out
Viking Therapeutics, Inc. performance
1D
−5.5%
7D
−11.0%
30D
−19.4%
90D
−30.1%
1Y
−26.8%
About Viking Therapeutics, Inc.
Viking Therapeutics, Inc. is a biotechnology company based in the United States, listed on NASDAQ since 2015 (ticker VKTX).
Viking Therapeutics, Inc. market data
What is the price of Viking Therapeutics, Inc. today?
Viking Therapeutics, Inc. (VKTX) is at $26.65, −5.50% on the day.
What is the 52-week range of Viking Therapeutics, Inc.?
Over the past year Viking Therapeutics, Inc. has traded between $25.77 and $43.15. It is currently 5% of the way up that range.
Similar stocks
RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
$3.84−4.4%
ZURA
Zura Bio Ltd
$4.23+7.1%
TCRT
Alaunos Therapeutics, Inc. Common Stock
$3.03+75.1%
SCNI
Scinai Immunotherapeutics Ltd. American Depositary Shares
$1.23−21.2%
BDRX
Biodexa Pharmaceuticals PLC
$0.3502−16.0%
PDSB
PDS Biotechnology Corporation
$1.60+11.9%
MRNA
Moderna, Inc.
$216.25+4.2%
PURR
Hyperliquid Strategies Inc.
$10.23+0.8%
Prices are snapshots from market data providers and may be delayed. This page is for information only and is not investment advice.